How do you measure a year? Time? Worldly events? Personal growth? There are many things that you could measure the time of the year against. Here...
The article 2022 Review: 3 Trials Pushing Boundaries of Psychedelic Medicine was originally published on Microdose. In my most recent article, The Top...
The article 2022 End of Year Review: Small Pharma was originally published on Microdose. Continuing our end-of-year review, we’ll take a moment to update...
Wellbeing Digital Sciences Inc.= (NEO: MEDI | OTC: KONEF | FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation...
From a new congressional caucus to the protection of indigenous knowledge, leaders in the field reflect on this year's significant events in the psychedelic...
The article 2022 End of Year Review: atai Life Sciences was originally published on Microdose. The end of the year is a convenient time to look...
The article Small Pharma Completes Phase IIa Trial and Secures New IP was originally published on Microdose. DMT-development firm Small Pharma has moved...
VANCOUVER – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF), a biotechnology company and global leader in first-in-class psilocybin-based...
The article 2022 End of Year Review: Cybin was originally published on Microdose. The end of the year is a convenient time to look back and...
Also a peek at their plans for the year ahead. The post How 5 Psychedelics Companies Fared in 2022 appeared first on Green Market Report.